Drug intelligence / Profile preview

Viva-C

Development stage: Unknown
Lead developer: CellMed
Modality: Small Molecules
Administration: Oral

Overview

Viva-C is a vitamin C dietary supplement developed by Cellmed Bio, a brand under JBK Lab. Formulated as oral granules, it is primarily indicated for the treatment and prevention of vitamin C deficiency, as well as for immune system support and general nutritional supplementation. The active ingredient, ascorbic acid, serves as a vital antioxidant and an essential enzymatic cofactor for various physiological processes, including collagen synthesis and the maintenance of immune cell function. The product is marketed as a consumer health supplement and is distributed through pharmacies.

Brand names: Viva-C
Other names: 비바씨 과립Viva-C granules

Targets

LH (Procollagen-lysine, 2-oxoglutarate 5-dioxygenase 1)PHD1 (Prolyl hydroxylase domain-containing protein 1)

Beyond the preview

Go deeper on Viva-C.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Viva-C.

Explore the full profile